Taking people in United StatesNo phase
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Key facts
- Where
- Fountain Valley, United StatesSee the site
Where in United States
- Doheny Eye Center UCLAFountain Valley, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of California, Los Angeles
- Trial code
- NCT04354545
- Record updated
- 13 March 2026
- Original description
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.Read full original descriptionShow less
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Inclusion: Currently using one or more topical glaucoma antihypertensives; Self-described symptoms of ocular surface discomfort; Xiidra is being prescribed as part of the subject's standard care.
Exclusion: current use of topical steroids; incisional ocular surgery within 6 months; History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.),; current use of topical cyclosporine.